{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:20:59Z","timestamp":1790266859931,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-76-10090"],"award-info":[{"award-number":["24-76-10090"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent liver disorders globally, affecting approximately 25% to 40% of the adult population. Closely associated with metabolic syndrome, obesity, insulin resistance, and dyslipidemia, NAFLD presents a growing burden due to its increasing incidence and high healthcare costs. In this context, the development of effective preventive and therapeutic strategies remains a pressing challenge in modern medicine. This review aims to analyze current scientific evidence on bioactive plant compounds\u2014particularly polyphenols and polyprenols\u2014including their natural sources, mechanisms of action, and potential applications in the prevention and dietary management of NAFLD. A growing body of evidence demonstrates that both polyphenols and polyprenols exert hepatoprotective, antioxidant, anti-inflammatory, and hypolipidemic effects. These compounds modulate signaling pathways implicated in hepatic steatosis and fibrosis, positively influence gut microbiota composition, and affect bile acid metabolism. Studies have confirmed the efficacy of polyphenol-rich foods (naringenin, resveratrol, chlorogenic acid, etc.) and polyprenol-based formulations in reducing body weight and liver steatosis, improving biochemical markers and insulin resistance. The combined application of polyphenols and polyprenols may yield synergistic effects on multiple pathogenic pathways and represents a promising direction for the dietary prevention and management of NAFLD.<\/jats:p>","DOI":"10.3390\/molecules30183791","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:24:25Z","timestamp":1758198265000},"page":"3791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Food Minor Bioactive Compounds of Polyphenolic and Polyprenolic Nature Are Promising Agents for the Prevention and Therapy of Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-5538","authenticated-orcid":false,"given":"Anastasiya","family":"Balakina","sequence":"first","affiliation":[{"name":"Federal Research Centre of Nutrition and Biotechnology, Moscow 109240, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-2659","authenticated-orcid":false,"given":"Yuliya","family":"Sidorova","sequence":"additional","affiliation":[{"name":"Federal Research Centre of Nutrition and Biotechnology, Moscow 109240, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-6002","authenticated-orcid":false,"given":"Nikita","family":"Petrov","sequence":"additional","affiliation":[{"name":"Federal Research Centre of Nutrition and Biotechnology, Moscow 109240, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0015-8735","authenticated-orcid":false,"given":"Vladimir","family":"Shipelin","sequence":"additional","affiliation":[{"name":"Federal Research Centre of Nutrition and Biotechnology, Moscow 109240, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref_1","first-page":"14","article-title":"Comparative characteristics of in vivo models of hyperlipidemia in Wistar rats and C57BL\/6 mice","volume":"85","author":"Apryatin","year":"2016","journal-title":"Vopr. Pitan."},{"key":"ref_2","first-page":"452","article-title":"Effect of a diet high in fats and carbohydrates on neuromotor function, cognitive, integral, and biochemical parameters in rats and mice of different lines","volume":"104","author":"Mzhelskaya","year":"2018","journal-title":"Ross. Fiziol. Zhurnal Im. IM Sechenova"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e13987","DOI":"10.14814\/phy2.13987","article-title":"Comparative analysis of the influence of a high-fat\/high-carbohydrate diet on the level of anxiety and neuromotor and cognitive functions in Wistar and DAT-KO rats","volume":"7","author":"Apryatin","year":"2019","journal-title":"Physiol. Rep."},{"key":"ref_4","unstructured":"Gmoshinsky, I.V., Shipelin, V.A., Apryatin, S.A., Trusov, N.V., Riger, N.A., and Shumakova, A.A. (2022). Effector Links of Metabolism. Biologically Active Food Substances in the Treatment of Obesity: From Theory and Model to Practice, Eksmo."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kravchenko, L.V., Aksenov, I.V., Nikitin, N.S., Guseva, G.V., Avrenyeva, L.I., Trusov, N.V., Balakina, A.S., and Tutelyan, V.A. (2021). Lipoic acid exacerbates oxidative stress and lipid accumulation in the liver of Wistar rats fed a hypercaloric choline-deficient diet. Nutrients, 13.","DOI":"10.3390\/nu13061999"},{"key":"ref_6","first-page":"221","article-title":"Effect of resveratrol on the development of non-alcoholic fatty liver disease in rats fed a high-fat high-fructose diet","volume":"20","author":"Trusov","year":"2024","journal-title":"Biomeditsina"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.5455\/jabet.2024.d52","article-title":"Effect of lipoic acid on the expression of nonalcoholic fatty liver disease-associated genes in t he liver of rats fed a hypercaloric choline-deficient diet","volume":"7","author":"Balakina","year":"2024","journal-title":"J. Adv. Biotechnol. Exp. Ther."},{"key":"ref_8","first-page":"1344","article-title":"Comparative analysis of the full transcriptome profile of the liver of Wistar rats fed diets with different fat, fructose, and cholesterol content","volume":"84","author":"Apryatin","year":"2019","journal-title":"Biochemistry"},{"key":"ref_9","first-page":"369","article-title":"Full transcriptome profiling of the liver of C57Black\/6J mice fed diets high in fat, fructose, and cholesterol","volume":"55","author":"Apryatin","year":"2019","journal-title":"Genetika"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14341\/probl12561","article-title":"Full transcriptome analysis of gene expression in the liver of mice in a comparative study of the effectiveness of quercetin in two models of obesity","volume":"66","author":"Trusov","year":"2020","journal-title":"Probl. Endokrinol."},{"key":"ref_11","first-page":"1141","article-title":"Effect of carnitine, resveratrol, and aromatic amino acid supplements to a high-fat and fructose diet on gene expression in the liver of rats: A full transcriptome study","volume":"57","author":"Trusov","year":"2021","journal-title":"Genetika"},{"key":"ref_12","first-page":"83","article-title":"Comparative assessment of the effects of resveratrol and carnitine on the full transcriptome profile of liver tissue in mice with different predispositions to the development of alimentary obesity","volume":"54","author":"Trusov","year":"2021","journal-title":"Vestn. Tomsk Gos. Univ. Biol."},{"key":"ref_13","first-page":"25","article-title":"Effector links of metabolism in diet-induced and genetically determined obesity: A full transcriptome study of liver tissue in experimental models in rodents","volume":"8","author":"Apryatin","year":"2023","journal-title":"Acta Biomed. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_15","first-page":"973","article-title":"Modification of nutritional patterns in patients with non-alcoholic steatohepatitis","volume":"94","author":"Sasunova","year":"2022","journal-title":"Ter. Arkh."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_17","first-page":"41","article-title":"Cost analysis of ademetionine treatment in patients with intrahepatic cholestasis and non-alcoholic fatty liver disease","volume":"1","author":"Zhuravleva","year":"2022","journal-title":"Klin. Prakt."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Neufingerl, N., and Eilander, A. (2021). Nutrient Intake and Status in Adults Consuming Plant-Based Diets Compared to Meat-Eaters: A Systematic Review. Nutrients, 14.","DOI":"10.3390\/nu14010029"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6621644","DOI":"10.1155\/2021\/6621644","article-title":"Plant-based foods and their bioactive compounds on fatty liver disease: Effects, mechanisms, and clinical application","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_20","first-page":"21","article-title":"Use of a polyprenol-containing drug in patients with acute coronary syndrome","volume":"33","author":"Tsoi","year":"2018","journal-title":"Sib. Med. J."},{"key":"ref_21","first-page":"104","article-title":"New hepatological and neurological clinical effects of long-chain plant polyprenols acting on the mammalian isoprenoid pathway","volume":"11","author":"Sultanov","year":"2016","journal-title":"Eksp. Klin. Gastroenterol."},{"key":"ref_22","first-page":"97","article-title":"Efficiency of the new herbal hepatoprotector Ropren in the treatment of patients with non-alcoholic steatohepatitis","volume":"7","author":"Golovanova","year":"2010","journal-title":"Eksp. Klin. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., and Ge, J. (2022). Efficacy and Safety of Dietary Polyphenol Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.949746"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Benavoli, L., Larussa, T., Corea, A., Procopio, A.C., Boccuto, L., Dallio, M., Federico, A., and Luzza, F. (2021). Dietary polyphenols and non-alcoholic fatty liver disease. Nutrients, 13.","DOI":"10.3390\/nu13020494"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"154979","DOI":"10.1016\/j.phymed.2023.154979","article-title":"Interactions between Gut Microbiota and Polyphenols: A Mechanistic and Metabolomic Review","volume":"119","author":"Cheng","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110189","DOI":"10.1016\/j.foodres.2021.110189","article-title":"Role of Dietary Polyphenols on Gut Microbiota, Their Metabolites and Health Benefits","volume":"142","author":"Wichienchot","year":"2021","journal-title":"Food Res. Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Daza, M.C., Pulido-Mateos, E.C., Lupien-Meilleur, J., Guyonnet, D., Desjardins, Y., and Roy, D. (2021). Polyphenol-mediated gut microbiota modulation: Toward prebiotics and further. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.689456"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wang, X., Qi, Y., and Zheng, H. (2022). Dietary polyphenol, gut microbiota, and health benefits. Antioxidants, 11.","DOI":"10.3390\/antiox11061212"},{"key":"ref_29","first-page":"29","article-title":"Systemic inflammation and non-alcoholic fatty liver disease","volume":"5","author":"Lazebnik","year":"2019","journal-title":"Eksp. Klin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Guo, X., Yin, X., Liu, Z., and Wang, J. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415489"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33029\/2304-9529-2024-13-2-35-46","article-title":"Management of patients with metabolic-associated fatty liver disease: An endocrinologist\u2019s view","volume":"13","author":"Ametov","year":"2024","journal-title":"Endocrinol. News Opin. Train."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3350\/cmh.2020.0129","article-title":"The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease","volume":"27","author":"Jennison","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Hong, D.G., and Yang, Y.M. (2021). Hepatokines and non-alcoholic fatty liver disease: Linking liver pathophysiology to metabolism. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121903"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The Role of Hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wu, L., Li, J., Feng, J., Ji, J., Yu, Q., Li, Y., Zheng, Y., Dai, W., Wu, J., and Guo, C. (2021). Crosstalk between PPARs and gut microbiota in NAFLD. Biomed. Pharmacother., 136.","DOI":"10.1016\/j.biopha.2021.111255"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/DDDT.S229063","article-title":"Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-\u03b3 Pathway","volume":"14","author":"Xiang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Luo, W., Xu, Q., Wang, Q., Wu, H., and Hua, J. (2017). Effect of Modulation of PPAR-\u03b3 Activity on Kupffer Cells M1\/M2 Polarization in the Development of Non-Alcoholic Fatty Liver Disease. Sci. Rep., 7.","DOI":"10.1038\/srep44612"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Forlano, R., Sivakumar, M., Mullish, B.H., and Manousou, P. (2022). Gut microbiota\u2014A future therapeutic target for people with non-alcoholic fatty liver disease: A systematic review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158307"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ranneh, Y., Bedir, A.S., Abu-Elsaoud, A.M., and Al Raish, S. (2024). Polyphenol intervention ameliorates non-alcoholic fatty liver disease: An updated comprehensive systematic review. Nutrients, 16.","DOI":"10.3390\/nu16234150"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chen, J., Huang, Z., Cao, X., Chen, X., Zou, T., and You, J. (2022). Plant-Derived Polyphenols as Nrf2 Activators to Counteract Oxidative Stress and Intestinal Toxicity Induced by Deoxynivalenol in Swine: An Emerging Research Direction. Antioxidants, 11.","DOI":"10.3390\/antiox11122379"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ciupei, D., Coli\u015far, A., Leopold, L., St\u0103nil\u0103, A., and Diaconeasa, Z.M. (2024). Polyphenols: From Classification to Therapeutic Potential and Bioavailability. Foods, 13.","DOI":"10.3390\/foods13244131"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9932218","DOI":"10.1155\/2021\/9932218","article-title":"Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal, P., Garc\u00eda-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., and Gonz\u00e1lez, A. (2008). Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol., 8.","DOI":"10.1186\/1471-230X-8-40"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/S0007114511002753","article-title":"Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress","volume":"107","author":"Macarulla","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, X.X., Xu, Y.Y., Wu, R., Chen, Z., Fang, K., Han, Y.X., Yu, Y., Huang, L.-L., Peng, L., and Ge, J.-F. (2019). Resveratrol reduces glucolipid metabolic dysfunction and learning and memory impairment in a NAFLD rat model: Involvement in regulating the imbalance of nesfatin-1 abundance and copine 6 expression. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00434"},{"key":"ref_49","first-page":"1198","article-title":"Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats","volume":"54","author":"Ali","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13813455.2018.1441872","article-title":"Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease","volume":"125","author":"Hajighasem","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e5522","DOI":"10.7717\/peerj.5522","article-title":"Effects of resveratrol, exercises and their combination on Farnesoid X receptor, Liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver","volume":"6","author":"Hajighasem","year":"2018","journal-title":"PeerJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","article-title":"Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats","volume":"52","author":"Xin","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nguyen, V., Taine, E.G., Meng, D., Cui, T., and Tan, W. (2024). Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials. Nutrients, 16.","DOI":"10.3390\/nu16070924"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shi, A., Li, T., Zheng, Y., Song, Y., Wang, H., Wang, N., Dong, L., and Shi, H. (2021). Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.693048"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113513","DOI":"10.1016\/j.foodres.2023.113513","article-title":"Indole-3-carbinol and chlorogenic acid combination modulates gut microbiome and attenuates nonalcoholic steatohepatitis in a murine model","volume":"174","author":"Bacil","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Peng, J.H., Leng, J., Tian, H.J., Yang, T., Fang, Y., Feng, Q., Zhao, Y., and Hu, Y.-Y. (2018). Geniposide and chlorogenic acid combination ameliorates non-alcoholic steatohepatitis involving the protection on the gut barrier function in mouse induced by high-fat diet. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01399"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bcp.2019.04.018","article-title":"Telmisartan and\/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase\/sphingoine-1-phosphate pathway, and TLR4 receptors","volume":"164","author":"Alqarni","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Liu, S., Liu, J., He, L., Liu, L., Cheng, B., Zhou, F., Cao, D., and He, Y. (2022). A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health. Molecules, 27.","DOI":"10.3390\/molecules27144400"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, R., Yao, Y., Gao, P., and Bu, S. (2021). The therapeutic efficacy of curcumin vs. metformin in modulating the gut microbiota in NAFLD rats: A comparative study. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.555293"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"He, Y., Wang, H., Lin, S., Chen, T., Chang, D., Sun, Y., Wang, C., Liu, Y., Lu, Y., and Song, J. (2023). Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115279"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.14341\/probl9284","article-title":"Phenotyping animal models of diabetic peripheral neuropathy in rats: Advantages and limitations","volume":"64","author":"Abdulvapova","year":"2018","journal-title":"Probl. Endokrinol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Amato, A., Caldara, G.F., Nuzzo, D., Baldassano, S., Picone, P., Rizzo, M., Mul\u00e8, F., and Di Carlo, M. (2017). NAFLD and atherosclerosis are prevented by a natural dietary supplement containing curcumin, silymarin, guggul, chlorogenic acid and inulin in mice fed a high-fat diet. Nutrients, 9.","DOI":"10.3390\/nu9050492"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1002\/ptr.7144","article-title":"Quercetin and Metabolic Syndrome: A Review","volume":"35","author":"Hosseini","year":"2021","journal-title":"Phyther. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nutres.2023.08.006","article-title":"Biological Activities of Naringenin: A Narrative Review Based on in Vitro and in Vivo Studies","volume":"119","year":"2023","journal-title":"Nutr. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Pipitone, R.M., Zito, R., Gambino, G., Di Maria, G., Javed, A., Lupo, G., Giglia, G., Sardo, P., Ferraro, G., and Rappa, F. (2023). Red and golden tomato administration improves fat diet-induced hepatic steatosis in rats by modulating HNF4\u03b1, Lepr, and GK expression. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1221013"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Yang, Y., Wu, Y., Zou, J., Wang, Y.H., Xu, M.X., Huang, W., Yu, D.-J., Zhang, L., Zhang, Y.-Y., and Sun, X.-D. (2021). Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.687095"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"114387","DOI":"10.1016\/j.intimp.2025.114387","article-title":"Research Progress on Pharmacokinetics, Anti-Inflammatory and Immunomodulatory Effects of Kaempferol","volume":"152","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, C., Li, Y., Li, R., Wang, J., Wu, C., Chen, H., Shi, Y., Wang, S., and Gao, C. (2025). Kaempferol Inhibits Oxidative Stress and Reduces Macrophage Pyroptosis by Activating the NRF2 Signaling Pathway. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0325189"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yang, H., Li, D., and Gao, G. (2024). Kaempferol alleviates hepatic injury in nonalcoholic steatohepatitis (NASH) by suppressing neutrophil-mediated NLRP3-ASC\/TMS1-caspase 3 signaling. Molecules, 29.","DOI":"10.3390\/molecules29112630"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Li, N., Yin, L., Shang, J., Liang, M., Liu, Z., Yang, H., Qiang, G., Du, G., and Yang, X. (2023). Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115113"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5599997","DOI":"10.1155\/2021\/5599997","article-title":"Epigallocatechin-3-gallate alleviates high-fat diet-induced nonalcoholic fatty liver disease via inhibition of apoptosis and promotion of autophagy through the ROS\/MAPK signaling pathway","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Du, Y., Paglicawan, L., Soomro, S., Abunofal, O., Baig, S., Vanarsa, K., Hicks, J., and Mohan, C. (2021). Epigallocatechin-3-gallate dampens non-alcoholic fatty liver by modulating liver function, lipid profile and macrophage polarization. Nutrients, 13.","DOI":"10.3390\/nu13020599"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"17999","DOI":"10.1002\/jcp.28432","article-title":"Theaflavin 3,3\u2032-digallate Reverses the Downregulation of Connexin 43 and Autophagy Induced by High Glucose via AMPK Activation in Cardiomyocytes","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhou, C., Zhang, W., Lin, H., Zhang, L., Wu, F., Wang, Y., Yu, S., Peng, X., Cheng, W., and Li, M. (2022). Effect of theaflavin-3,3\u2032-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1\/PPAR\u03b4\/Fabp4 axis and gut microbiota. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.925264"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1039\/D1NR06690K","article-title":"The Management of Diabetes Mellitus by Mangiferin: Advances and Prospects","volume":"14","author":"Wang","year":"2022","journal-title":"Nanoscale"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4084566","DOI":"10.1155\/2021\/4084566","article-title":"Mangiferin ameliorates HFD-induced NAFLD through regulation of the AMPK and NLRP3 inflammasome signal pathways","volume":"2021","author":"Yong","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.biopha.2017.10.022","article-title":"Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice","volume":"96","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Li, J., Liu, M., Yu, H., Wang, W., Han, L., Chen, Q., Ruan, J., Wen, S., Zhang, Y., and Wang, T. (2018). Mangiferin improves hepatic lipid metabolism mainly through its metabolite-norathyriol by modulating SIRT-1\/AMPK\/SREBP-1c signaling. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00201"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lin, H., Teng, H., Wu, W., Li, Y., Lv, G., Huang, X., Yan, W., and Lin, Z. (2020). Pharmacokinetic and metabolomic analyses of mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-020-00438-x"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/ptr.8217","article-title":"Luteolin: A Promising Multifunctional Natural Flavonoid for Human Diseases","volume":"38","author":"Zhu","year":"2024","journal-title":"Phyther. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"155834","DOI":"10.1016\/j.phymed.2024.155834","article-title":"Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota","volume":"132","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"117990","DOI":"10.1016\/j.lfs.2020.117990","article-title":"Combination of luteolin and lycopene effectively protect against the \u201ctwo-hit\u201d in NAFLD through Sirt1\/AMPK signal pathway","volume":"256","author":"Zhu","year":"2020","journal-title":"Life Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3177\/jnsv.69.259","article-title":"Luteolin ameliorates hepatic steatosis and enhances mitochondrial biogenesis via AMPK\/PGC-1\u03b1 pathway in Western diet-fed mice","volume":"69","author":"Wang","year":"2023","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbrc.2016.11.101","article-title":"Luteolin improves non-alcoholic fatty liver disease in db\/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c","volume":"482","author":"Yin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_89","first-page":"647832","article-title":"Effects on liver lipid metabolism of the naturally occurring dietary flavone luteolin-7-glucoside","volume":"2015","author":"Oliveira","year":"2015","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Oriquat, G., Masoud, I.M., Kamel, M.A., Aboudeya, H.M., Bakir, M.B., and Shaker, S.A. (2023). The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK\/MTOR\/Lipogenesis Pathways. Molecules, 28.","DOI":"10.3390\/molecules28041734"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Landa, J.F., German-Ponciano, L.J., Puga-Olgu\u00edn, A., and Olmos-V\u00e1zquez, O.J. (2022). Pharmacological, Neurochemical, and Behavioral Mechanisms Underlying the Anxiolytic- and Antidepressant-like Effects of Flavonoid Chrysin. Molecules, 27.","DOI":"10.3390\/molecules27113551"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Campanher, G., Andrade, N., Lopes, J., Silva, C., Pena, M.J., Rodrigues, I., and Martel, F. (2025). The counteracting effect of chrysin on dietary fructose-induced metabolic-associated fatty liver disease (MAFLD) in rats with a focus on glucose and lipid metabolism. Molecules, 30.","DOI":"10.3390\/molecules30020380"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jpp\/rgad041","article-title":"Chrysin prevents inflammation-coinciding liver steatosis via AMPK signalling","volume":"75","author":"Gao","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00210-019-01705-3","article-title":"Chrysin ameliorates nonalcoholic fatty liver disease in rats","volume":"392","author":"Pai","year":"2019","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9479456","DOI":"10.1155\/2022\/9479456","article-title":"Chrysin attenuates fructose-induced nonalcoholic fatty liver in rats via antioxidant and anti-inflammatory effects: The role of angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas receptor axis","volume":"2022","author":"Attia","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Vanaga, I., Gubernator, J., Nakurte, I., Kletnieks, U., Muceniece, R., and Jansone, B. (2020). Identification of Abies sibirica L. polyprenols and characterisation of polyprenol-containing liposomes. Molecules, 25.","DOI":"10.3390\/molecules25081801"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ptr.6327","article-title":"Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis","volume":"33","author":"Khodanovich","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.phrs.2016.03.040","article-title":"Pharmacological research on natural substances in Latvia: Focus on lunasin, betulin, polyprenol and phlorizin","volume":"113","author":"Muceniece","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Tao, R., Wang, C., Ye, J., Zhou, H., and Chen, H. (2016). Polyprenols of Ginkgo biloba enhance antibacterial activity of five classes of antibiotics. Biomed. Res. Int., 2016.","DOI":"10.1155\/2016\/4191938"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fitote.2015.09.008","article-title":"Synthesis and biological activity of polyprenols","volume":"106","author":"Zhang","year":"2015","journal-title":"Fitoterapia"},{"key":"ref_101","first-page":"71","article-title":"The hepatoprotector Ropren for the treatment of patients with nonalcoholic steatohepatitis: A prospective observational study","volume":"9","author":"Golovanova","year":"2016","journal-title":"Eksp. Klin. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.physbeh.2016.01.035","article-title":"Cognitive-enhancing activities of the polyprenol preparation Ropren\u00ae in gonadectomized \u03b2-amyloid (25\u201335) rat model of Alzheimer\u2019s disease","volume":"157","author":"Fedotova","year":"2016","journal-title":"Physiol. Behav."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cytogfr.2016.04.001","article-title":"New polyprenyl phosphate-based preparation Fortepren\u00ae as promising cytokine regulating antiviral remedy","volume":"30","author":"Pronin","year":"2016","journal-title":"Cytokine. Growth. Factor. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10517-018-4159-x","article-title":"Hypolipidemic and hepatoprotective effects of a polyprenol-containing drug in patients with acute coronary syndrome","volume":"165","author":"Vyshlov","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.fitote.2011.04.009","article-title":"Hepatoprotective effects of polyprenols from Ginkgo biloba L. leaves on CCl4-induced hepatotoxicity in rats","volume":"82","author":"Yang","year":"2011","journal-title":"Fitoterapia"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jep.2012.04.030","article-title":"Polyprenols from Taxus chinensis var. mairei prevent the development of CCl4-induced liver fibrosis in rats","volume":"142","author":"Yu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.15789\/1563-0625-IEO-16729","article-title":"Immunobiological efficacy of a new drug based on sodium polyprenyl phosphate for the treatment and prevention of metabolic syndrome in an experiment","volume":"26","author":"Pronin","year":"2024","journal-title":"Med. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00005-013-0253-y","article-title":"Plant polyisoprenoids and control of cholesterol level","volume":"62","author":"Pronin","year":"2014","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_109","unstructured":"Narovlyansky, A.N., Pronin, A.V., Sanin, A.V., Veselovsky, V.V., Danilov, L.L., Sedov, A.M., and Veselovsky, V.V. (2018). Isoprenoids: Polyprenols and Polyprenyl Phosphates as Physiologically Important Metabolic Regulators, Nova Science Publishers."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11130-018-0698-6","article-title":"Silver fir (Abies alba) extracts inhibit enzymes involved in blood glucose management and protect against oxidative stress in high glucose environment","volume":"74","author":"Lunder","year":"2019","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.indcrop.2013.10.005","article-title":"Chemical composition of the silver fir (Abies alba) bark extract Abigenol\u00ae and its antioxidant activity","volume":"52","author":"Grohar","year":"2014","journal-title":"Ind. Crop. Prod."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Leone, K., Micheletto, M., Di Maira, G., Tedesco, E., Benetti, F., and Zaloker, U. (2022). Role of a novel silver fir (Abies alba) extract, Abigenol\u00ae\/AlbiPhenol\u00ae, in modulating cardiovascular disorders: Key factors. Antioxidants, 11.","DOI":"10.3390\/antiox11040618"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"152927","DOI":"10.1016\/j.phymed.2019.152927","article-title":"Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family","volume":"64","author":"Fox","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.31557\/APJCP.2018.19.12.3393","article-title":"Cytotoxic and antiproliferative activity of polyisoprenoids in seventeen mangroves species against widr colon cancer cells","volume":"19","author":"Sari","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jam.2005.18.55","article-title":"A prototype prophylactic anti-influenza preparation in aerosol form on the basis of Abies sibirica polyprenols","volume":"18","author":"Safatov","year":"2005","journal-title":"J. Aerosol Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/18\/3791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:45Z","timestamp":1760035665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/18\/3791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":115,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["molecules30183791"],"URL":"https:\/\/doi.org\/10.3390\/molecules30183791","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}